Why not?
By then they should have 2 drugs in market with U$3B revenue at 90% margins and another $10B one close...plus any others added in the interim. $12B at 90% = $10.8B net revenue - less overheads (relatively minor) and at say 10x PE would give the co a market cap of circa $108B.
OK, so all may not make it, revenue might not be as much as advertised, risks need to be factored in etc....but no doubt the potential is there and $35B is around 1/3 of that potential.
So, again, why not?
- Forums
- ASX - By Stock
- PYC Filed Another Patent
Why not?By then they should have 2 drugs in market with U$3B...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
|
|||||
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $489.9M |
Open | High | Low | Value | Volume |
10.5¢ | 11.0¢ | 10.5¢ | $5.5K | 50.00K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 1206782 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 716545 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 1206782 | 0.105 |
28 | 1938465 | 0.100 |
1 | 5100 | 0.098 |
1 | 50000 | 0.096 |
7 | 207605 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 716545 | 9 |
0.115 | 1308522 | 10 |
0.120 | 878830 | 7 |
0.125 | 522274 | 6 |
0.130 | 1074815 | 11 |
Last trade - 11.04am 25/07/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online